Myocardial fibrosis associated with aldosterone or angiotensin II administration: Attenuation by calcium channel blockade

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 3, 1998, Pages 475-483

  Ramires, Felix J A ^a   Sun, Yao ^a   Weber, Karl T ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Aldosterone; Angiotensin II; Calcium channel blocker; Myocardial fibrosis

Indexed keywords

ALDOSTERONE; ALPHA ACTIN; ANGIOTENSIN; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; COLLAGEN; HYDROXYPROLINE; MIBEFRADIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL GROWTH; COLLAGEN METABOLISM; CONTROLLED STUDY; HEART MUSCLE FIBROSIS; HEART PROTECTION; HYPERALDOSTERONISM; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SALT INTAKE; SECOND MESSENGER; VIDEODENSITOMETRY;

EID: 0032031528     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0612     Document Type: Article

References (65)

1. BERNINK PJ, PRAGER G, SCHELLING A, KOBRIN I, 1996. Antihypertensive properties of the novel calcium antagonist mibefradil (Ro 40-5967). A new generation of calcium antagonists? Mibefradil International Study Group. Hypertension 27: 426-432.
2. 2+ channel antagonist Ro 40-5967 in vascular muscle cells cultured from dog coronary and saphenous arteries. Naunyn Schmiedebergs Arch Pharmacol 348: 191-196.
3. BONVALET JP, ALEAIDY N, FARMAN N, LOMBES M, 1995. Aldosterone: intracellular receptors in human heart. Eur Heart J 16 (Suppl. N): 92-97.
4. BRILLA CG, WEBER KT, 1992. Mineralocorticoid excess, dietary sodium and myocardial fibrosis. J Lab Clin Med 120: 893-901.
5. BRILLA CG, PICK R, TAN LB, JANICKI JS, WEBER KT, 1990. Remodeling of the rat right and left ventricle in experimental hypertension. Circ Res 67: 1355-1364.
6. BRILLA CG, MATSUBARA LS, WEBER KT, 1993. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 25: 563-575.
7. BRILLA CG, ZHOU G, MATSUBARA L, WEBER KT, 1994. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 26: 809-820.
8. BROCK TA, ALEXANDER RW, EKSTEIN LS, ATKINSON RW, GIMBRONE MA JR, 1985. Angiotensin increases cytosolic fre calcium in cultured vascular smooth muscle cells. Hypertension 7: I105-I109.
9. BUCKLEY NE, SU Y, MILSTIEN S, SPIEGEL S, 1995. The role of calcium influx in cellular proliferation induced by interaction of endogenous ganglioside GM1 with the B subunit of cholera toxin. Biochim Biophys Acta 1256: 275-283.
10. CAMPBELL SE, JANICKI JS, WEBER KT, 1995. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J Mol Cell Cardiol 27: 1545-1560.
11. CAROZZI S, NASINI MG, CANTALUPPI A, SALIT M, 1992. Peritoneal dialysis solution calcium concentration regulates peritoneal fibroblast proliferation in CAPD. ASAIO J 38: M585-M588.
12. 2+ influx induced by vasoactive hormones or depletion of intracellular calcium stores. Arzneimittelforschung 47: 244-247.
13. CHIARIELLO M, AMBROSIO G, CAPPELLI-BIGAZZI M, PERRONE-FILARDI P, BRIGANTE F, SIFOLA C, 1986. A biochemical method for the quantitation of myocardial scarring after experimental coronary artery occlusion. J Mol Cell Cardiol 18: 283-290.
14. CLEUTJENS JPM, VERLUYTEN MJA, SMITS JFM, DAEMEN MJAP, 1995. Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol 147: 325-338.
15. i) elevation by angiotensin II (AII) and platelet derived growth factor-BB (PDGF-BB) in human vascular smooth muscle cells (VSCMs). Biochem Soc Trans 23: 170S.
16. CRAWFORD DC, CHOBANIAN AV, BRECHER P, 1994. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res 74: 727-739.
17. DOOLAN CM, HARVEY BJ, 1996. Rapid effects of steroid hormones on free intracellular calcium in T84 colonic epithelial cells. Am J Physiol 271: C1935-C1941.
18. DOYLE JW, ROTH TP, SMITH RM, LI YQ, DUNN RM, 1996. Effects of calcium alginate on cellular wound healing processes modeled in vitro. J Biomed Mater Res 32: 561-568.
19. ESTACION M, 1991. Characterization of ion channels seen in subconfluent human dermal fibroblasts. J Physiol 436: 579-601.
20. GAMARRA F, SIMIC-SCHLEICHER G, HUBER RM, ULSENHEIMER A, SCRIBA PC, KUHNLE U, WEHLING M, 1997. Impaired rapid mineralocorticoid action on free intracellular calcium in pseudohypoaldosteronism. J Clin Endocrinol Metab 82: 831-834.
21. GOLDBLATT H, 1938. Experimental hypertension induced by renal ischemia (Harvey Lecture). Bull NY Acad Med 14: 523-553.
22. GRAVES LM, HE Y, LAMBERT J, HUNTER D, LI X, EARP HS, 1997. An intracellular calcium signal activates p70 but not p90 ribosomal S6 kinase in liver epithelial cells. J Biol Chem 272: 1920-1928.
23. GRIENDLING KK, RITTENHOUSE SE, BROCK TA, EKSTEIN LS, GIMBRONE MA JR, ALEXANDER RW, 1986. Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J Biol Chem 261: 5901-5906.
24. HALL CE, HALL O, 1965. Hypertension and hypersalimentation. I. Aldosterone hypertension. Lab Invest 14: 285-294.
25. HOUCHI H, OKUNO M, KITAMURA K, ISHIMURA Y, OHUCHI T, TOKUMURA A, OKA M, 1995. Stimulatory effect of angiotensin II on calcium efflux from cultured bovine adrenal chromaffin cells. Life Sci 56: PL109-PL114.
26. JOHNSTON CI, 1990. Biochemistry and pharmacology of the renin-angiotensin system. Drugs 39 (Suppl. 1): 21-31.
27. KARAM H, HEUDES D, HESS P, GONZALES MF, LOFFLER BM, CLOZEL M, CLOZEL JP, 1996. Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats. Cardiovasc Res 31: 287-295.
28. LEE AA, DILLMANN WH, MCCULLOCH AD, VILLARREAL FJ, 1995. Angiotensin II stimulates the autocrine production of transforming growth factor-β1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 27: 2347-2357.
29. LI JS, SCHIFFRIN E, 1996. Effect of calcium channel blockade or angiotensin-coverting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats. J Cardiovasc Pharmacol 28: 68-74.
30. LOMBES M, ALFAIDY N, EUGENE E, LESSANA A, FARMAN N, BONVALET J-P, 1995. Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase in the human heart. Circulation 92: 175-182.
31. 2+ channels. J Pharmacol Exp Ther 271: 1483-1488.
32. 2+ channels by Ro 40-5967. Circ Res 75: 144-148.
33. MUNZENMAIER DH, GREENE AS, 1995. Angiotensin II mediates a sustained rise in nuclear and cytoplasmic calcium via multiple receptor subtypes. Am J Physiol 269: H656-H1570.
34. NICKENIG G, GEISEN G, VETTER H, SACHINIDIS A, 1997. Characterization of angiotensin receptors on human skin fibroblasts. J Mol Med 75: 217-222.
35. OU R, SUN Y, GANJAM VK, WEBER KT, 1996. In situ production of angiotensin II by fibrosed rat pericardium. J Mol Cell Cardiol 28: 1319-1327.
36. PEARCE P, FUNDER JW, 1987. High affinity aldosterone binding sites (type I receptors) in rat heart. Clin Exp Pharmacol Physiol 14: 859-866.
37. RATAJSKA A, CAMPBELL SE, CLEUTJENS JPM, WEBER KT, 1994a. Angiotensin II and structural remodeling of coronary vessels in rats. J Lab Clin Med 124: 408-415.
38. RATAJSKA A, CAMPBELL SE, SUN Y, WEBER KT, 1994b. Angiotensin II associated cardiac myocyte necrosis: role of adrenal catecholamines. Cardiovasc Res 28: 684-690.
39. ROBERT V, SILVESTRE JS, CHARLEMAGNE D, SABRI A, TROUVÉ P, WASSEF M, SWYNGHEDAUW B, DELCAYRE C, 1995. Biological determinants of aldosterone-induced cardiac fibrosis in rats. Hypertension 26: 971-978.
40. 1 receptor subtype. Circ Res 73: 413-423.
41. SCHNEIDER M, ULSENHEIMER A, CHRIST M, WEHLING M, 1997. Nongenomic effects of aldosterone on intracellular calcium in porcine endothelial cells. Am J Physiol 272: E616-E620.
42. SCHORB W, BOOZ GW, DOSTAL DE, CONRAD KM, CHANG KC, BAKER KM, 1993. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 72: 1245-1254.
43. SIGUSCH HH, OU R, KATWA LC, CAMPBELL SE, GANJAM VK, REDDY HK, WEBER KT, 1995. Angiotensin-II-induced increase in transcoronary protein clearance: role of hypertension vs. nitric oxide or cyclo-oxygenase products. Cardiovasc Res 30: 291-298.
44. SILVER MA, PICK R, BRILLA CG, JALIL JE, JANICKI JS, WEBER KT, 1990. Reactive and reparative fibrosis in the hypertrophied rat left ventricle: two experimental models of myocardial fibrosis. Cardiovasc Res 24: 741-747.
45. SLIGHT S, GANJAM VK, NONNEMAN DJ, WEBER KT, 1993. Glucocorticoid metabolism in the cardiac interstitium: 11β-hydroxysteroid dehydrogenase activity in cardiac fibroblasts. J Lab Clin Med 122: 180-187.
46. +-dependent 11β-hydroxysteroid dehydrogenase in the human heart. J Mol Cell Cardiol 28: 781-787.
47. SORRENTINO R, CIRINO G, CALIGNANO A, MANCUSO F, SORRENTINO L, ANDRIUOLI G, PINTO A, 1996. Increase in the basal tone of guinea pig thoracic aorta induced by ouabain is inhibited by spironolactone canrenone and potassium canrenoate. J Cardiovasc Pharmacol 28: 519-525.
48. SUN Y, MENDELSOHN FAO, 1991. Angiotensin coverting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril. J Cardiovasc Pharmacol 18: 478-486.
49. SUN Y, WEBER KT, 1994. Fibrosis and myocardial ACE: possible substrate and independence from circulating angiotensin II. J Cardiac Failure 1: 81-89.
50. SUN Y, WEBER KT, 1996a. Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol 28: 851-858.
51. SUN Y, WEBER KT, 1996b. Angiotensin-converting enzyme and wound healing in diverse tissues of the rat. J Lab Clin Med 127: 94-101.
52. SUN Y, RATAJSKA A, ZHOU G, WEBER KT, 1993. Angiotensin converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone. J Lab Clin Med 122: 395-403.
53. SUN Y, CLEUTJENS JPM, DIAZ-ARIAS AA, WEBER KT, 1994. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res 28: 1423-1432.
54. SUN Y, RATAJSKA A, WEBER KT, 1995. Bradykinin receptor and tissue ACE binding in myocardial fibrosis: response to chronic angiotensin II or aldosterone administration in rats. J Mol Cell Cardiol 27: 813-822.
55. SUN Y, RAMIRES FJA, WEBER KT, 1997. Fibrosis of atria and great vessels in reponse to angiotensin II or aldosterone infusion. Cardiovasc Res 35: 138-147.
56. TANAKA K, HONDA M, KURAMOCHI T, HASHIMOTO M, MASUMURA S, MANSOOR AM, ISHIKAWA S, MORIOKA S, 1994a. Different effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on protein metabolism in rats with right ventricular hypertrophy. J Hypertens 12: 1147-1154.
57. TANAKA K, HONDA M, KURAMOCHI T, MORIOKA S, 1994b. Prominent inhibitory effects of tranilast on migration and proliferation of and collagen synthesis by vascular smooth muscle cells. Life Sci 107: 179-185.
58. VILLARREAL FJ, KIM NN, UNGAB GD, PRINTZ MP, DILLMANN WH, 1993. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 88: 2849-2861.
59. WEBER KT, BRILLA CG, 1991. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 83: 1849-1865.
60. WEBER KT, SUN Y, GUARDA E, KATWA L, RATAJSKA A, CLEUTJENS J, ZHOU G, 1995. Myocardial fibrosis in hypertensive heart disease: an overview of potential regulatory mechanisms. Eur Heart J 16 (Suppl. C): 24-28.
61. 2+ in vascular smooth muscle cells. Circ Res 76: 973-979.
62. WELLING A, LACINOVA L, DONATIN K, LUDWIG A, BOSSE E, FLOCKERZI V, HOEMANN F, 1995. Expression of the L-type calcium with two different beta subunits and its modulation by Ro 40-5967. Pflügers Arch 429: 400-411.
63. YOUNG M, FULLERTON M, DILLEY R, FUNDER J, 1994. Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest 93: 2578-2583.
64. YOUNG M, HEAD G, FUNDER J, 1995. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol 269: E657-E662.
65. ZHOU G, KANDALA JC, TYAGI SC, KATWA LC, WEBER KT, 1996. Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol Cell Biochem 154: 171-178.